STACEY SAMS: Open Payments
NPI 1619459641 · LOGAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 67 payments from 17 companies in 2025. Trend: 2023 $2,313 · 2024 $1,722 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $223 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Aimmune Therapeutics, Inc. | 1 | $114 |
| Amgen Inc. | 5 | $87 |
| Novo Nordisk Inc | 5 | $83 |
| Lilly USA, LLC | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
Products named: ZENPEP, BREZTRI, QULIPTA, VRAYLAR, MOUNJARO, XIFAXAN, OTEZLA, Ozempic.
Industry payments across OH — which companies pay providers there.
